📰 Alectin News
Alectin News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alectin. Real-time updates on events, politics, business and more.
March 30, 2023
Item 2.02 Results of Operations and Financial Condition. On March 30, 3023, Galectin Therapeutics Inc. issued a press release announcing its results of operations and financial condition as of and... | March 30, 2023
October 12, 2022
NORCROSS, Ga., Oct. 12, 2022 -- Galectin Therapeutics, Inc. , the leading developer of therapeutics that target galectin-3, today announced that its Investigational New Drug application for... | October 12, 2022
November 23, 2021
Environmentally-mediated drug resistance in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) significantly contributes to relapse. Stromal cells in the bone marrow environment protect leukemia cells by secretion of chemokines as cues for BCP-ALL migration towards, and adhesion to, stroma. Stromal cells and BCP-ALL cells communicate through stromal galectin-3. Here, we investigated the significance of stromal galectin-3 to BCP-ALL cells. We used CRISPR/Cas9 genome editing to ablate galecti...